Improving outcomes for people with skin tumours including melanoma

Improving Outcomes for
People with Skin Tumours
including Melanoma
Appendix 2
b) This document is the scope. It defines exactly what this piece of
service guidance will (and will not) examine, and what the
developers will consider. The scope is based on the referral
from the Department of Health and Welsh Assembly
Government (see page 131).
c) The areas that will be addressed by the guideline are described
in the following sections.
4.1 Population
A2
4.1.1 Groups that will be covered
a) Adults with malignant tumours of the skin (basal cell carcinoma,
squamous cell carcinoma, malignant melanoma and other rare
primary tumours).
b) Adults with primary cutaneous lymphomas.
c) Adults with skin tumours arising in immuno-compromised
patients.
d) Children and young people in their late teens and early twenties
presenting with skin tumours typical of the adult group, whose
management does not generally require specialist paediatric
oncology services.
e) Adults and children with precancerous skin lesions such as
actinic keratoses, Bowen’s and lentigo maligna, including the
specific needs of people with genetic disorders.
4.1.2 Groups that will not be covered
a) Adults and children with benign skin tumours.
b) Adults and children with cutaneous metastases from tumours at
other primary sites.
4.2 Healthcare setting and services
4.2.1 Healthcare settings and services that will be covered
a) Primary care, including diagnosis, treatment and follow-up.
b) Secondary care, including the role of skin cancer networks and
multidisciplinary teams.
c) Tertiary care in cancer centres, specialist dermatology centres
and specialist plastic surgery units.
132
National Institute for Health and Clinical Excellence